Scarpignato, C., & Lanas, A. (2013). Gastric mucosal safety of traditional non-steroidal anti-inflammatory drugs and selective COX-2 inhibitors in patients with osteoarthritis. Current Medical Research and Opinion, 29(1), 1-18.
Mahmood, A., FitzGerald, A. J., Marchbank, T., Ntatsaki, E., Murray, D., Ghosh, S., & Playford, R. J. (2007). Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut, 56(2), 168-175.
Playford, R. J., MacDonald, C. E., & Johnson, W. S. (2000). Coloprotective agents for the prevention of NSAID-induced enteropathy. Alimentary Pharmacology & Therapeutics, 14(10), 1307-1315.
Shimada, T., Watanabe, N., Ohtsuka, Y., & Shiratori, Y. (1990). Prevention by zinc L-carnosine of the gastric ulcerogenic and healing-impairing actions of non-steroidal anti-inflammatory drugs in rats. The Journal of Pharmacology and Experimental Therapeutics, 255(3), 1101-1106.
Suzuki, H., Mori, M., Seto, K., Miyamoto, T., & Uchiyama, F. (1999). Polaprezinc (Zinc L-carnosine) is a therapeutic option for Helicobacter pylori-positive gastric ulcer. Journal of Gastroenterology and Hepatology, 14(5), 439-444.
Tarnawski, A. (2005). Cellular and molecular mechanisms of gastrointestinal ulcer healing. Digestive Diseases and Sciences, 50(s2), S3-S14.